(0.04%) 5 519.00 points
(0.11%) 39 889 points
(0.11%) 19 772 points
(-0.06%) $81.58
(0.50%) $2.83
(-0.25%) $2 338.50
(0.17%) $29.58
(0.42%) $1 006.00
(0.07%) $0.932
(-0.09%) $10.52
(0.00%) $0.788
(-0.85%) $87.25
73.79% $ 0.0179
Live Chart Being Loaded With Signals
Cingulate Inc., a clinical-stage biopharmaceutical company, focuses on the development of product candidates for the treatment of central nervous system and neurobiological disorders...
Stats | |
---|---|
Dzisiejszy wolumen | 500 |
Średni wolumen | 0 |
Kapitalizacja rynkowa | 7.47M |
EPS | $-0.600 ( Q1 | 2024-05-08 ) |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E |
-0.0100 (Sector) 42.63 (Industry) 24.32 |
ATR14 | $0 (0.00%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2023-12-29 | Silva Raul R. | Buy | 1 000 | Stock Option (right to Buy) |
2023-09-29 | Silva Raul R. | Buy | 10 000 | Stock Option (right to Buy) |
2023-09-15 | Callahan Jennifer L. | Buy | 5 000 | Common Stock |
2023-09-08 | Werth Peter J. | Buy | 6 838 235 | Pre-Funded Warrant (right to buy) |
2023-08-11 | Werth Peter J. | Buy | 1 823 155 | Common Stock |
INSIDER POWER |
---|
100.00 |
Last 79 transactions |
Buy: 10 002 264 | Sell: 8 300 |
Cingulate Inc. Korelacja
10 Najbardziej pozytywne korelacje |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Cingulate Inc. Finanse
Annual | 2023 |
Przychody: | $0 |
Zysk brutto: | $-582 918 (0.00 %) |
EPS: | $-26.01 |
FY | 2023 |
Przychody: | $0 |
Zysk brutto: | $-582 918 (0.00 %) |
EPS: | $-26.01 |
FY | 2022 |
Przychody: | $0 |
Zysk brutto: | $-621 993 (0.00 %) |
EPS: | $-31.57 |
FY | 2021 |
Przychody: | $0.00 |
Zysk brutto: | $0.00 (0.00 %) |
EPS: | $0 |
Financial Reports:
No articles found.
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Cingulate Inc.
Cingulate Inc., a clinical-stage biopharmaceutical company, focuses on the development of product candidates for the treatment of central nervous system and neurobiological disorders. The company\'s lead product candidates are CTx-1301 (dexmethylphenidate) and CTx-1302 (dextroamphetamine) for the treatment of attention deficit/hyperactivity disorders. It also focuses on developing CTx-2103 for the treatment of anxiety disorders. The company was founded in 2012 and is headquartered in Kansas City, Kansas with an additional location in Morristown, New Jersey.
O Sygnały na żywo
Prezentowane na tej stronie sygnały na żywo pomagają określić, kiedy KUPIĆ lub SPRZEDAĆ BRAK DANYCH. Sygnały mogą mieć opóźnienie wynoszące nawet 1 minutę; jak wszystkie sygnały rynkowe, istnieje ryzyko błędu lub pomyłki.
Sygnały transakcyjne na żywo nie są ostateczne i getagraph.com nie ponosi odpowiedzialności za żadne działania podjęte na podstawie tych sygnałów, jak opisano w Warunkach Użytkowania. Sygnały opierają się na szerokim zakresie wskaźników analizy technicznej